Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-04-19 @ 2:58 AM
Study NCT ID:
NCT05220267
Status:
UNKNOWN
Last Update Posted:
2022-02-02
First Post:
2021-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma
Sponsor:
Organization: